✦ LIBER ✦

Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease

✍ Scribed by J. Maj; Z. Rogóż; G. Skuza; H. Sowińska; J. Superata

Book ID: 105517860
Publisher: Springer
Year: 1990
Tongue: English
Weight: 718 KB
Volume: 2
Category: Article
ISSN: 1435-1463
DOI: 10.1007/bf02260898

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of entacapone, a COMT inhibitor,

Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease

✍ V. V. Myllylä; K. A. Sotaniemi; A. Illi; K. Suominen; T. Keränen 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 563 KB

In an open, randomised, cross-over study we investigated the effect of a single 200 mg oral dose of entacapone, a novel catechol-O-methyltransferase (COMT) inhibitor, on the pharmacokinetics and metabolism of levodopa/carbidopa, and on the cardiovascular responses (blood pressure and pulse rate vari

MDL 72,974: a potent and selective enzym

MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease

✍ Monique Zreika; J. R. Fozard; M. W. Dudley; Ph. Bey; I. A. McDonald; M. G. Palfr 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 742 KB